Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2916-2921

  Fotsis, Theodore ^a,d   Pepper, Michael S ^b   Aktas, Erkan ^a   Breit, Stephen ^a,e   Rasku, Sirpa ^c   Adlercreutz, Herman ^c   Wähälä, Kristiina ^c   Montesano, Roberto ^b   Schweigerer, Lothar ^a,e  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF IOANNINA   (Greece)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIHYDROXYFLAVONE; 3 HYDROXYFLAVONE; 3',4' DIHYDROXYFLAVONE; APIGENIN; CATECHIN; COUMARIN; FISETIN; FLAVANONE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL; GENISTEIN; LUTEOLIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; CHRONIC DISEASE; DIETARY INTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; ANTICARCINOGENIC AGENTS; CATTLE; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; HUMANS; MITOSIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030741461     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Klagsbrun, M., and Folkman, J. Angiogenesis. In: M. B. Sporn and A. B. Roberts (eds.), Peptide Growth Factors and Their Receptors II, pp. 549-586. Berlin: Springer-Verlag, 1990.
2. Denekamp, J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev., 9: 267-282, 1990.
3. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
4. Folkman, J., and Cotran, R. S. Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol., 16: 207-248, 1976.
5. Adlercreutz, H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Stand. J. Clin. Lab. Invest., 50 (Suppl. 201): 3-23, 1990.
6. Miller, A. B. Diet and cancer: a review. Rev. Oncol., 3: 87-95, 1990.
7. Rose, D. P., Boyar, A. P., and Wynder, E. L. International comparison of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita fat consumption. Cancer (Phila.), 58: 2363-2371, 1986.
8. Kolonel, L. N. Variability in diet and its relation to risk in ethnic and migrant groups. Basic Life Sci., 43: 129-135, 1988.
9. Lee, H. P., Courley, L., and Duffy, S. W. Dietary effects on breast cancer risk in Singapore. Lancet, 337: 1197-1200, 1991.
10. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90: 2690-2694, 1993.
11. Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr., 125 (Suppl.): 790S-797S, 1995.
12. Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., Hämäläinen, E., Hasegawa, T., and Okada, H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am. J. Clin. Nutr., 54: 1093-1100, 1991.
13. Adlercreutz, H., Fotsis, T., Bannwart, C., Wähälä, K., Brunow, G., and Hase, T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin. Chim. Acta, 199: 263-278, 1991.
14. Adlercreutz, H., Van der Wildt, J., Kinzel, J., Attalla, H., Wähälä, K., Mäkelä, T., Hase, T., and Fotsis, T. Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem. Mol. Biol., 52: 97-103, 1995.
15. Harborne, J. B. Flavonoids. In: L. P. Miller (ed.), Phytochemistry, pp. 344-380. New York: Van Nostrand Reinhold Co., 1973.
16. Harborne, J. B., and Marby, T. J. The Flavonoids: Advances in Research. London: Chapman and Hall Ltd., 1982.
17. Middleton, E., Jr. Some biological properties of plant flavonoids. Annals of Allergy, 61: 53-57, 1988.
18. Kiljunen, H., and Hase, T. Titration of organolithiums and grignards with 1-pyrene-acetic acid. J. Org. Chem., 56: 6950-6952, 1991.
19. Hoshino, Y., and Takeno, N. Ortho substituent effect of the side-chain phenyl group on the dehydrogenation of flavanones with 2,3-dichloro-5,6-dicyano-p-benzoquinone. Bull. Chem. Soc. Jpn., 60: 4468-4470, 1987.
20. Arcoleo, A., Bellino, A., Casinovi, C., and Venturella, P. Flavones of the veratrole series. Ann. Chim. (Rome), 520: 75-70, 1957.
21. Wollenweher, E., Mann, K., Iimura, M. Tanala, T., and Mizuno, M. 8,2α-Dihydroxyflavone from primula pulverulenta. Phytochemistry, 27: 1483-1486, 1988.
22. Nagarathman, D., and Cushman, M. A short and facile synthetic route to hydroxylated flavones. New syntheses of apigenin, tricin, and luteolin. J. Org. Chem. 56: 4884-4887, 1991.
23. Schweigerer, L., Breit, S., Wenzel, A., Tsunamoto, K., Ludwig, R., and Schwab, M. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth activity. Cancer Res., 50: 4411-4416, 1990.
24. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., and Gospodarowicz, D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (Lond.), 325: 257-259, 1987.
25. Schweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes, J. C., and Gospodarowicz, D. Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc. Natl. Acad. Sci. USA, 84: 842-846, 1987.
26. Montesano, R., and Orci, L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell, 42: 469-477, 1985.
27. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 18: 824-831, 1992.
28. Montesano, R., Vassalli, J-D., Baird, A., Guillemin, R., and Orci, L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA, 83: 7297-7301, 1986.
29. Schweigerer, L., Christeleit, K., Fleischmann, G., Adlercreutz, H., Wähälä, K., Hase, T., Schwab, M., Ludwig, R., and Fotsis, T. Identification in human urine of a natural growth inhibitor for cells derived from solid pediatric tumors. Eur. J. Clin. Invest., 22: 260-264, 1992.
30. Fotsis, T., Pepper, M. S., Aktas, E., Joussen, A., Kruse, F., Adlercreutz, H., Wähälä, K., Hase, T., Montesano, R., and Schweigerer, L. Inhibitors of angiogenesis in human urine. In: M. E. Maragoudakis (ed.), Molecular, Cellular, and Clinical Aspects of Angiogenesis, pp. 213-227. New York: Plenum Press, 1996.
31. Kandaswami, C., Perkins, E., Soloniuk, D. S., Drzewiecki, G., and Middleton, E. J. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett., 56: 147-152, 1991.
32. Hirano, T., Abe, K., Gotoh, M., and Oka, K. Citrus flavone tangeretin inhibits leukemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer, 72: 1380-1388, 1995.
33. Yit, C. C., and Das, N. P. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett., 82: 65-72, 1994.
34. Huang, H. C., Wang, H. R., and Hsieh, L. M. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur. J. Pharmacol., 251: 91-93, 1994.
35. Pepper, M. S., and Montesano, R. Proteolytic balance and capillary morphogenesis. Cell Differ. Dev., 32: 319-328, 1990.
36. Havsteen, B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32: 1141-1148, 1983.
37. Graziani, Y., Erikson, E., and Erikson, R. L. The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo. Eur. J. Biochem., 135: 583-589, 1983.
38. Cunningham, B. D. M., Threadgill, M. D., Groundwater, P. W., Dale, I. L., and Hickman, J. A. Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anticancer Drus Des., 7: 365-384, 1992.
39. Ferriola, P. C., Cody, V., and Middleton, E. J. Protein kinase C inhibition by plant flavonoids. Bioehem. Pharmacol., 38: 1617-1624, 1989.
40. Huang, Y. T., Kuo, M. L., Liu, J. Y., Huang, S. Y., and Lin, J. K. Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by apigenin. Eur. J. Cancer, 32A: 146-151, 1996.
41. Singhal, R. L., Yeh, Y. A., Praja, N., Olah, E., Sledge, G. W. J., and Weber, G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem. Biophys. Res. Commun., 208: 425-431, 1995.
42. Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., and Worland, P. J. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 201: 589-595, 1994.
43. 1 arrst with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2473-2478, 1996.
44. De Azevedo, W. F., Mueller-Dieckmann, H. J., Schulze-Gahman, U., Worland, P. J., Dausville, E., and Kim, S. H. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA, 93: 2735-2740, 1996.
45. Boege, F., Straub, T., Kehr, A., Boesenberg, C. Christiansen, K., Andersen, A., Jakob, F., and Kohrle, J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem., 271: 2262-2270, 1996.
46. Devasagayam, T. P., Subramanian, M., Singh, B. B., Ramanathan, R., and Das, N. P. Protection of plasmid pBR322 DNA by flavonoids against single-stranded breaks induced by singlet molecular oxygen. J. Photochem. Photobiol., 30: 97-103, 1995.
47. Hertog, M. G., Hollman, P. C., Katan, M. B., and Kromhout, D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer, 20: 21-29, 1993.
48. Das, A., Wang, J. H., and Lien, E. J. Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis. In: E. Jucker (ed.), Progress in Drug Research, pp. 133-166. Basel: Birkhaeuser Verlag, 1995.
49. Elangovan, V., Sekar, N., and Govindasamy, S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett., 87: 107-113, 1994.